Increase in the oxidized/total coenzyme q-10 ratio in the cerebrospinal fluid of alzheimer's disease patients

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 5, 2009, Pages 449-454

  Isobe, Chiaki ^a,b   Abe, Takashi ^b   Terayama, Yasuo ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Chitose Daiichi Hospital   (Japan)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Mitochondrial dysfunction; Oxidized coenzyme Q 10; Oxidized total coenzyme Q 10 ratio; Reduced coenzyme Q 10

Indexed keywords

UBIDECARENONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE DURATION; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; ELECTRON TRANSPORT; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; UBIQUINONE;

EID: 70449513452     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000256209     Document Type: Article

References (27)

1. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffa L, Haynes A, Irving N, James L: Segregation of missense mutation in the amyloid protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706. (Pubitemid 21912142)
2. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibon R, Tornell J, Jacobs HT, Larsson NG: Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-423.
3. Yasojima K, McGeer EG, McGeer PL: 3-Hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain. Neurosci Lett 2001; 297: 97-100.
4. Abe T, Tohgi H, Murata T, Isobe C, Sato C: Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 2001; 312: 177-179.
5. Murakami Y, Ohsawa I, Kasahara T, Ohta S: Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde. Neurobiol Aging 2007; 30: 325-329.
6. Ohta S, Ohsawa I: Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification. J Alzheimers Dis 2006; 99: 155-166.
7. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stem D, Yan SS, Wu H: ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004; 304: 448-452.
8. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S: Fish, meat, and risk of dementia: Cohort study. BMJ 2002; 325: 932-933.
9. Perry G, Castellani RJ, Smith MA, Harris PL, Kubat Z, Ghanbari K, Jones PK, Cordone G, Tabaton M, Wolozin B, Ghanbari H: Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol 2003; 106: 552-556. (Pubitemid 37441611)
10. Yamamoto Y, Kawamura M, Tatsuno K: Formation of lipid hydroperoxides in the cupric ion-induced oxidation of plasma and low density lipoprotein; in Davies KJA (ed): Oxidative Damage and Repair. New York, Pergamon Press, 1991, pp 287-291.
11. Yamamoto Y, Yamashita S: Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. Mol Aspects Med 1997; 18: S79-S84.
12. Jiménez-Jiménez FJ, Molina JA, de Bustos F, García-Redondo A, Gómez-Escalonilla C, Martínez-Salio A, Berbel A, Camacho A, Zurdo M, Barcenilla B, Enríquez de Salamanca R, Arenas J: Serum levels of coenzyme Q10 in patients with Parkinson's disease. J Neural Transm 2000; 107: 177-181. (Pubitemid 30095368)
13. de Bustos F, Molina JA, Jiménez-Jiménez FJ, Garcia-Rdondo A, Gomez-Escalonilla C, Porta-Etessam J, Berbel A, Zurdo M, Barcenilla B, Enriquez de Salamanca R, Arenas J: Serum levels of coenzyme Q10 in patients with Alzheimer's disease. J Neural Transm 2000; 107: 233-239. (Pubitemid 30095372)
14. Mariani C, Bresolin N, Farina E, Ferrante C, Clafaloni E, Sertorelli S, Ciccone A, Scarlato G: Muscle biopsy in Alzheimer's disease: Morphological and biochemical findings. Clin Neuropathol 1991; 10: 171-176.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), ed 4. Washington, American Psychiatric Association, 1994, pp 135-155.
16. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
17. Hachinski VC, Iliff LD, Zilhka E: Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-637.
18. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State'. A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
19. Isobe C, Murata T, Sato C, Terayama Y: Increased of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease. J Clin Neurosci 2007; 14: 340-343.
20. Murata T, Ohtsuka C, Terayama Y: Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 2008; 15: 66-69.
21. Upston JM, Terentis AC, Stocker R: Tocopherol-mediated peroxidation of lipoproteins: Implication for vitamin E as a potential antiatherogenic supplement. FASEB J 1999; 13: 977-994.
22. Shults CW, Haas RH, Passov D, Beal MF: Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 1997; 42: 261-264.
23. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA: 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997; 68: 2092-2097.
24. Murakami Y, Ohsawa I, Kasahara T, Ohta S: Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde. Neurobiol Aging 2009; 30: 325-329.
25. Okamoto T, Fukui K, Nakamoto M, Kishi T, Okishio T, Yamagami T, Kanamori N, Kishi H, Hiraoka E: High-performance liquid chromatography of coenzyme Q-related compounds and its application to biological materials. J Chromatogr 1985; 342: 35-46
26. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M; Parkinson Study Group: Effects of coenzyme Q10 in early Parkinson's disease: Evidence of slowing the functional decline. Arch Neurol 2002; 59: 1541-1550.
27. Wadsworth TL, Bishop JA, Pappu AS, Woltjer RL, Quinn JF: Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J Alzheimers Dis 2008; 14: 225-234.